NM_001005361.3:c.1129-40C>T

Variant summary

Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBS1BS2

The NM_001005361.3(DNM2):​c.1129-40C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00564 in 1,611,006 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).

Frequency

Genomes: 𝑓 0.0036 ( 3 hom., cov: 32)
Exomes 𝑓: 0.0059 ( 38 hom. )

Consequence

DNM2
NM_001005361.3 intron

Scores

2

Clinical Significance

Benign criteria provided, single submitter B:1

Conservation

PhyloP100: -0.118

Publications

0 publications found
Variant links:
Genes affected
DNM2 (HGNC:2974): (dynamin 2) Dynamins represent one of the subfamilies of GTP-binding proteins. These proteins share considerable sequence similarity over the N-terminal portion of the molecule, which contains the GTPase domain. Dynamins are associated with microtubules. They have been implicated in cell processes such as endocytosis and cell motility, and in alterations of the membrane that accompany certain activities such as bone resorption by osteoclasts. Dynamins bind many proteins that bind actin and other cytoskeletal proteins. Dynamins can also self-assemble, a process that stimulates GTPase activity. Five alternatively spliced transcripts encoding different proteins have been described. Additional alternatively spliced transcripts may exist, but their full-length nature has not been determined. [provided by RefSeq, Jun 2010]
DNM2 Gene-Disease associations (from GenCC):
  • autosomal dominant centronuclear myopathy
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), ClinGen, Ambry Genetics, Orphanet
  • Charcot-Marie-Tooth disease
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • Charcot-Marie-Tooth disease dominant intermediate B
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • autosomal dominant Charcot-Marie-Tooth disease type 2M
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • fetal akinesia-cerebral and retinal hemorrhage syndrome
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet
  • hereditary spastic paraplegia
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -14 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.87).
BP6
Variant 19-10795332-C-T is Benign according to our data. Variant chr19-10795332-C-T is described in ClinVar as Benign. ClinVar VariationId is 256863.Status of the report is criteria_provided_single_submitter, 1 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00362 (551/152334) while in subpopulation NFE AF = 0.00623 (424/68028). AF 95% confidence interval is 0.00574. There are 3 homozygotes in GnomAd4. There are 246 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 3 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001005361.3. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM2
NM_001005361.3
MANE Select
c.1129-40C>T
intron
N/ANP_001005361.1P50570-4
DNM2
NM_001005360.3
c.1129-40C>T
intron
N/ANP_001005360.1P50570-1
DNM2
NM_001190716.2
c.1129-40C>T
intron
N/ANP_001177645.1P50570-5

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
DNM2
ENST00000389253.9
TSL:5 MANE Select
c.1129-40C>T
intron
N/AENSP00000373905.4P50570-4
DNM2
ENST00000355667.11
TSL:1
c.1129-40C>T
intron
N/AENSP00000347890.6P50570-1
DNM2
ENST00000585892.5
TSL:1
c.1129-40C>T
intron
N/AENSP00000468734.1P50570-5

Frequencies

GnomAD3 genomes
AF:
0.00362
AC:
551
AN:
152216
Hom.:
3
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00123
Gnomad AMI
AF:
0.0351
Gnomad AMR
AF:
0.00137
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.00132
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00623
Gnomad OTH
AF:
0.00191
GnomAD2 exomes
AF:
0.00331
AC:
831
AN:
251238
AF XY:
0.00328
show subpopulations
Gnomad AFR exome
AF:
0.00117
Gnomad AMR exome
AF:
0.00162
Gnomad ASJ exome
AF:
0.0000992
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00243
Gnomad NFE exome
AF:
0.00561
Gnomad OTH exome
AF:
0.00456
GnomAD4 exome
AF:
0.00585
AC:
8536
AN:
1458672
Hom.:
38
Cov.:
30
AF XY:
0.00578
AC XY:
4199
AN XY:
725852
show subpopulations
African (AFR)
AF:
0.00105
AC:
35
AN:
33420
American (AMR)
AF:
0.00179
AC:
80
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0000766
AC:
2
AN:
26122
East Asian (EAS)
AF:
0.0000504
AC:
2
AN:
39676
South Asian (SAS)
AF:
0.00106
AC:
91
AN:
86200
European-Finnish (FIN)
AF:
0.00301
AC:
160
AN:
53188
Middle Eastern (MID)
AF:
0.00104
AC:
6
AN:
5752
European-Non Finnish (NFE)
AF:
0.00705
AC:
7821
AN:
1109330
Other (OTH)
AF:
0.00562
AC:
339
AN:
60276
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
452
904
1357
1809
2261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
304
608
912
1216
1520
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00362
AC:
551
AN:
152334
Hom.:
3
Cov.:
32
AF XY:
0.00330
AC XY:
246
AN XY:
74480
show subpopulations
African (AFR)
AF:
0.00123
AC:
51
AN:
41588
American (AMR)
AF:
0.00137
AC:
21
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4826
European-Finnish (FIN)
AF:
0.00132
AC:
14
AN:
10622
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00623
AC:
424
AN:
68028
Other (OTH)
AF:
0.00189
AC:
4
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.492
Heterozygous variant carriers
0
28
56
83
111
139
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00433
Hom.:
1
Bravo
AF:
0.00380
Asia WGS
AF:
0.000289
AC:
1
AN:
3478

ClinVar

ClinVar submissions
Significance:Benign
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.87
CADD
Benign
6.3
DANN
Benign
0.70
PhyloP100
-0.12
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199742926; hg19: chr19-10906008; API